However, in a paracrine manner, another study demonstrated that celecoxib enhanced overall CXCL10 expression in the glioma microenvironment through a decrease in myeloid-derived suppressor cells (MDSC), thus upregulating infiltration of CD8+ T cells into GBM [60] (Fig. 3). The gene discussed is CXCL10; the disease is central nervous system cancer.